Four bookable platforms, from sample to dataset.

Not every project starts with a clear parameter list. Our scoping service pairs you with our scientific team for a structured study of your question (bibliography, one or more scientific meetings, and a written protocol & parameter definition) before any platform below is booked.

A paid, bookable service, reserved like a platform slot. If the resulting project is booked with us, the scoping fee may be credited toward it: case by case, confirmed when you book. For a fuller engagement with a dedicated project lead through to publication, see GenXMap's Collaborative Research program.

DNA, cfDNA, RNA, small RNA, cfRNA and protein extraction, with documented QC on arrival, after extraction and before library preparation. Every batch ships with its QC report.

Sequencing and targeted quantification, from whole genome to a single gene target: genomics, transcriptomics, metagenomics and PCR-based assays, run on documented protocols with QC at every step.

Targeted and untargeted protein analysis for expression profiling and biomarker work.

Mass-spectrometry proteomics runs in-house. Biomarker panels are delivered with our specialized partner, MIPP: same single point of contact, same QC standards.

Cargo profiling: RNA and protein content of isolated vesicles, for biological signature and biomarker discovery.

Combine two or more services into a single coordinated project, with every layer generated from the same extraction batch. The examples below are starting points, and any combination can be scoped.

Examples above are illustrative starting points, not a fixed menu: tell us your project and we'll scope the right combination. Need the whole scientific project designed and run, not just the platforms booked: protocol design, connecting the right platforms, multi-omics data integration, through to publication? That's GenXMap's Collaborative Research program, with a dedicated PhD-level project lead as your single point of contact.

For projects where the biomarker is the deliverable, not the data. The platform combination is defined by the question rather than fixed in advance, and can draw on our own platforms, GenXMap's Computational Biology & AI, and our partner network.

Each joint platform began as a need, and became a workflow we built with our partners, bringing together complementary expertise and equipment. Distinct from our own Multi-Omics packages, which combine our categories in-house, each combo platform draws on one of our 4 categories, plus the dedicated expertise and equipment of one or more named partners.

Combo platform

In Vitro Testing Platform

×××

You send the molecule, we return the readout. With our partners, we select the human cell or tissue model, apply your compound and run the treatment. We then proceed with extraction, QC and transcriptomic profiling. One project, one point of contact, from compound to expression data.

Draws on: NGS & Molecular Biology Enquire about this platform

Combo platform

Exosome Characterization Platform

×

A dedicated exosome/EV characterization workflow combining OMICS4's isolation and cargo-analysis capacity with the Faculté de Pharmacie de Marseille's specialized nanoparticle-characterization equipment, built for higher-resolution EV sizing, count and marker validation than either partner runs alone.

Draws on: Exosomes & EVs Enquire about this platform

Combo platform

360° Transcriptomics Platform

××

Three views of the same transcriptome, on one design and one sample set. Bulk RNA-seq runs on our own platforms and tells you what changed; single-cell with Parean Biotechnologies tells you in which cells; spatial transcriptomics with Explicyte tells you where in the tissue. Bought separately the three rarely line up. Run together they are interpreted as one reading rather than three reports to reconcile.

Draws on: NGS & Molecular Biology (Transcriptomics) Enquire about this platform

The scientific detail is on genxmap.com.